Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. (Q54146372)

25 May 2018

title

Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. (English)

1 reference

25 May 2018

author name string

F R Hu

series ordinal

1

1 reference

25 May 2018

K T Luh

series ordinal

2

1 reference

25 May 2018

publication date

1 February 1998

1 reference

25 May 2018

published in

Ophthalmology

1 reference

25 May 2018

volume

105

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

269-272

1 reference

25 May 2018

Extensive lamellar keratectomy for treatment of nontuberculous mycobacterial keratitis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Ciprofloxacin therapy of Mycobacterium chelonae keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Nontuberculous mycobacterial keratitis. Report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

In-vitro susceptibility of mycobacteria to ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2898%2980018-3

7 January 2021

10.1016/S0161-6420(98)80018-3

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

9479286

1 reference

25 May 2018